Reading between the lines; understanding drug response in the post genomic era.

Mol Oncol 2014 Sep 10;8(6):1112-9. Epub 2014 Jun 10.

Cancer Genome Project, Wellcome Trust Sanger Institute, Cambridge, UK.

Following the fanfare of initial, often dramatic, success with small molecule inhibitors in the treatment of defined genomic subgroups, it can be argued that the extension of targeted therapeutics to the majority of patients with solid cancers has stalled. Despite encouraging FDA approval rates, the attrition rates of these compounds remains high in early stage clinical studies, with single agent studies repeatedly showing poor efficacy In striking contrast, our understanding of the complexity of solid neoplasms has increased in huge increments, following the publication of large-scale genomic and transcriptomic datasets from large collaborations such as the International Cancer Genome Consortium (ICGC http://www.icgc.org/) and The Cancer Genome Atlas (TCGA http://cancergenome.nih.gov/). However, there remains a clear disconnect between these rich datasets describing the genomic complexity of cancer, including both intra- and inter-tumour heterogeneity, and what a treating oncologist can consider to be a clinically "actionable" mutation profile. Our understanding of these data is in its infancy and we still find difficulties ascribing characteristics to tumours that consistently predict therapeutic response for the majority of small molecule inhibitors. This article will seek to explore the recent studies of the patterns and impact of mutations in drug resistance, and demonstrate how we may use this data to reshape our thinking about biological pathways, critical dependencies and their therapeutic interruption.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2014.05.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5528621PMC
September 2014
11 Reads

Publication Analysis

Top Keywords

molecule inhibitors
8
small molecule
8
cancer genome
8
atlas tcga
4
tcga http//cancergenomenihgov/
4
http//cancergenomenihgov/ remains
4
remains clear
4
genome atlas
4
repeatedly showing
4
icgc http//wwwicgcorg/
4
showing poor
4
http//wwwicgcorg/ cancer
4
clear disconnect
4
disconnect rich
4
cancer including
4
including intra-
4
intra- inter-tumour
4
complexity cancer
4
genomic complexity
4
rich datasets
4

Similar Publications